| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,279 |
3,410 |
$400K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
674 |
672 |
$76K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
526 |
525 |
$59K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
522 |
522 |
$59K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
235 |
223 |
$33K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
37 |
37 |
$5K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
116 |
105 |
$5K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,053 |
1,990 |
$5K |
| 90461 |
|
747 |
744 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
478 |
464 |
$473.37 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
595 |
593 |
$207.70 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
90 |
89 |
$177.94 |
| 99188 |
|
599 |
593 |
$173.76 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
741 |
336 |
$166.90 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
851 |
810 |
$122.16 |
| 81002 |
|
1,798 |
1,767 |
$107.67 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
179 |
160 |
$40.55 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
601 |
565 |
$27.74 |
| 85018 |
|
901 |
893 |
$21.23 |
| 90686 |
|
1,280 |
1,272 |
$0.00 |
| 97802 |
|
448 |
446 |
$0.00 |
| 90688 |
|
133 |
132 |
$0.00 |
| 82962 |
|
53 |
53 |
$0.00 |
| 90680 |
|
50 |
50 |
$0.00 |
| 87807 |
|
77 |
69 |
$0.00 |
| 90651 |
|
30 |
29 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
29 |
28 |
$0.00 |
| 92567 |
|
181 |
171 |
$0.00 |
| 90716 |
|
78 |
78 |
$0.00 |
| 90677 |
|
35 |
35 |
$0.00 |
| 96160 |
|
157 |
157 |
$0.00 |
| 90713 |
|
241 |
241 |
$0.00 |
| 90648 |
|
174 |
174 |
$0.00 |
| 90734 |
|
96 |
96 |
$0.00 |
| 90670 |
|
112 |
112 |
$0.00 |
| 90700 |
|
298 |
298 |
$0.00 |
| 90633 |
|
46 |
46 |
$0.00 |
| 90715 |
|
12 |
12 |
$0.00 |
| 90707 |
|
36 |
36 |
$0.00 |
| 99173 |
|
29 |
29 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
194 |
180 |
$0.00 |
| 90671 |
|
15 |
15 |
$0.00 |